Karimah Sabar - Profile and Investment Details

Investor Profile

Karimah Sabar is a Venture Capital, Private Equity Firm, Investment Partner based in Vancouver, Washington, United States with a diverse investment portfolio that includes companies such as ARTMS, Sitka Biopharma, CathWorks, Biscayne NeuroTherapeutics, PHEMI Systems, Microbion, Raziel Therapeutics, CalciMedica, Eloxx, EnClear Therapies, Physiq, Raziel Health, MSI Methylation Sciences, Biscayne Pharmaceuticals, Volastra Therapeutics, Keros Therapeutics, SQZ Biotech, Canary Medical, Eyevensys, Lyndra Therapeutics, V-Wave, Bioarray Therapeutics, Pi Therapeutics. Over time, Karimah Sabar has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Karimah Sabar is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Information Technology (IT), Biotech, Medical Device, Healthcare, Biotechnology, Clinical Trials, Medical, Real Estate, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Karimah Sabar, as their portfolio suggests a familiarity and interest in this area.

Understanding Karimah Sabar’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.